https://scholars.lib.ntu.edu.tw/handle/123456789/547782
標題: | Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: A prospective population-based cohort study | 作者: | Su Y.-N. Hung C.-C. SHIN-YU LIN Chen F.-Y. Chern J.P.S. Tsai C. Chang T.-S. Yang C.-C. Li H. HONG-NERNG HO CHIEN-NAN LEE |
公開日期: | 2011 | 卷: | 6 | 期: | 2 | 起(迄)頁: | e17067 | 來源出版物: | PLoS ONE | 摘要: | Background: Spinal muscular atrophy (SMA) is the most common neuromuscular autosomal recessive disorder. The American College of Medical Genetics has recently recommended routine carrier screening for SMA because of the high carrier frequency (1 in 25-50) as well as the severity of that genetic disease. Large studies are needed to determine the feasibility, benefits, and costs of such a program. Methods and Findings: This is a prospective population-based cohort study of 107,611 pregnant women from 25 counties in Taiwan conducted during the period January 2005 to June 2009. A three-stage screening program was used: (1) pregnant women were tested for SMA heterozygosity; (2) if the mother was determined to be heterozygous for SMA (carrier status), the paternal partner was then tested; (3) if both partners were SMA carriers, prenatal diagnostic testing was performed. During the study period, a total of 2,262 SMA carriers with one copy of the SMN1 gene were identified among the 107,611 pregnant women that were screened. The carrier rate was approximately 1 in 48 (2.10%). The negative predictive value of DHPLC coupled with MLPA was 99.87%. The combined method could detect approximately 94% of carriers because most of the cases resulted from a common single deletion event. In addition, 2,038 spouses were determined to be SMA carriers. Among those individuals, 47 couples were determined to be at high risk for having offspring with SMA. Prenatal diagnostic testing was performed in 43 pregnant women (91.49%) and SMA was diagnosed in 12 (27.91%) fetuses. The prevalence of SMA in our population was 1 in 8,968. Conclusion: The main benefit of SMA carrier screening is to reduce the burden associated with giving birth to an affected child. In this study, we determined the carrier frequency and genetic risk and provided carrier couples with genetic services, knowledge, and genetic counseling. ? 2011 Su et al. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-79952157125&doi=10.1371%2fjournal.pone.0017067&partnerID=40&md5=caa5d60a66cdeafb2b7bcd407814a13d https://scholars.lib.ntu.edu.tw/handle/123456789/547782 |
ISSN: | 1932-6203 | DOI: | 10.1371/journal.pone.0017067 | SDG/關鍵字: | survival motor neuron protein 1; survival motor neuron protein 2; SMN1 protein, human; survival motor neuron protein 1; adult; article; cohort analysis; controlled study; denaturing high performance liquid chromatography; diagnostic test; ethnicity; female; genotype; gestational age; heterozygosity; heterozygote detection; human; major clinical study; multiplex ligation dependent probe amplification; multiplex polymerase chain reaction; muscle weakness; parity; population research; prediction; pregnant woman; prenatal diagnosis; prevalence; prospective study; spinal muscular atrophy; Taiwan; trend study; clinical trial; evaluation; genetic counseling; genetic screening; genetics; heterozygote; heterozygote detection; methodology; multicenter study; population genetics; predictive value; pregnancy; pregnant woman; prenatal diagnosis; spinal muscular atrophy; time; Adult; Cohort Studies; Female; Genetic Counseling; Genetic Testing; Genetics, Population; Heterozygote; Heterozygote Detection; Humans; Muscular Atrophy, Spinal; Predictive Value of Tests; Pregnancy; Pregnant Women; Prenatal Diagnosis; Prospective Studies; Survival of Motor Neuron 1 Protein; Time Factors; Young Adult |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。